Novel nitroxoline derivative combating resistant bacterial infections through outer membrane disruption and competitive NDM-1 inhibition

References

• Nordmann, P, Poirel L, Walsh TR, et al. The emerging NDM carbapenemases. Trends Microbiol. 2011;19:588–595. doi:10.1016/j.tim.2011.09.005
   PubMed Web of Science ®Google Scholar
• Wang T, et al. Recent research and development of NDM-1 inhibitors. Eur J Med Chem. 2021;223:113667. doi:10.1016/j.ejmech.2021.113667
   PubMed Web of Science ®Google Scholar
• Wu W, Feng Y, Tang G, et al. NDM metallo-beta-lactamases and their bacterial producers in health care settings. Clin Microbiol Rev; 2019;32(2).
   PubMed Web of Science ®Google Scholar
• Iredell J, Brown J, Tagg K. Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ. 2016;352:h6420.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538–582. doi:10.1128/CMR.00058-07
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Thirunarayan MA, Krishnan P. Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother. 2010;65:2253–2254. doi:10.1093/jac/dkq273
   PubMed Web of Science ®Google Scholar
• Li Y, Qiu Y, Fang C, et al. Coexistence of bla(OXA-58) and bla(NDM-1) on a Novel Plasmid of GR59 from an Acinetobacter towneri isolate. Antimicrob Agents Chemother. 2022; 66:e0020622.
   PubMed Web of Science ®Google Scholar
• Zhang X. Human in check: new threat from superbugs equipped with NDM-1. Protein Cell. 2010;1:1051–1052. doi:10.1007/s13238-010-0134-7
   PubMed Web of Science ®Google Scholar
• Albur MS, Noel A, Bowker K, et al. The combination of colistin and fosfomycin is synergistic against NDM-1-producing Enterobacteriaceae in in vitro pharmacokinetic/pharmacodynamic model experiments. Int J Antimicrob Agents. 2015;46:560–567. doi:10.1016/j.ijantimicag.2015.07.019
   PubMed Web of Science ®Google Scholar
• Docobo-Perez F, et al. Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. Int J Antimicrob Agents. 2012;39:251–254. doi:10.1016/j.ijantimicag.2011.10.012
   PubMed Web of Science ®Google Scholar
• El-Sayed Ahmed MAE, Zhong L-L, Shen C, et al. Colistin and its role in the Era of antibiotic resistance: an extended review (2000-2019). Emerg Microbes Infect. 2020;9:868–885. doi:10.1080/22221751.2020.1754133
   PubMed Web of Science ®Google Scholar
• Hao J, Zhang B, Deng J, et al. Emergence of a hypervirulent tigecycline-resistant klebsiella pneumoniae strain Co-producing bla (NDM-1) and bla (KPC-2) With an uncommon sequence type ST464 in southwestern China. Front Microbiol. 2022;13:868705. doi:10.3389/fmicb.2022.868705
   PubMed Web of Science ®Google Scholar
• He T, Wang R, Liu D, et al. Emergence of plasmid-mediated high-level tigecycline resistance genes in animals and humans. Nat Microbiol. 2019;4:1450–1456. doi:10.1038/s41564-019-0445-2
   PubMed Web of Science ®Google Scholar
• Jiang S, Wang X, Yu H, et al. Molecular antibiotic resistance mechanisms and co-transmission of the mcr-9 and metallo-beta-lactamase genes in carbapenem-resistant Enterobacter cloacae complex. Front Microbiol. 2022;13:1032833. doi:10.3389/fmicb.2022.1032833
   PubMedGoogle Scholar
• Zheng B, Dong H, Xu H, et al. Coexistence of MCR-1 and NDM-1 in clinical Escherichia coli isolates. Clin Infect Dis. 2016;63:1393–1395. doi:10.1093/cid/ciw553
   PubMed Web of Science ®Google Scholar
• Atanasov AG, Zotchev SB, Dirsch VM, et al. Natural products in drug discovery: advances and opportunities. Nat Rev Drug Discov. 2021;20:200–216. doi:10.1038/s41573-020-00114-z
   PubMed Web of Science ®Google Scholar
• Schein CH. Repurposing approved drugs on the pathway to novel therapies. Med Res Rev. 2020;40:586–605. doi:10.1002/med.21627
   PubMed Web of Science ®Google Scholar
• Fuchs F, Becerra-Aparicio F, Xanthopoulou K, et al. In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract. J Antimicrob Chemother. 2022;77:1912–1915. doi:10.1093/jac/dkac123
   PubMed Web of Science ®Google Scholar
• Pelletier C, Prognon P, Bourlioux P. Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains. Antimicrob Agents Chemother. 1995;39:707–713. doi:10.1128/AAC.39.3.707
   PubMed Web of Science ®Google Scholar
• Latrache H, Bourlioux P, Karroua M, et al. Effects of subinhibitory concentrations of nitroxoline on the surface properties of Escherichia coli. Folia Microbiol (Praha). 2000;45:485–490. doi:10.1007/BF02818714
   PubMed Web of Science ®Google Scholar
• Abouelhassan Y, Yang Q, Yousaf H, et al. Nitroxoline: a broad-spectrum biofilm-eradicating agent against pathogenic bacteria. Int J Antimicrob Agents. 2017;49:247–251. doi:10.1016/j.ijantimicag.2016.10.017
   PubMed Web of Science ®Google Scholar
• Wijma RA, Huttner A, Koch BCP, et al. Review of the pharmacokinetic properties of nitrofurantoin and nitroxoline. J Antimicrob Chemother. 2018;73:2916–2926. doi:10.1093/jac/dky255
   PubMed Web of Science ®Google Scholar
• Proschak A, Martinelli G, Frank D, et al. Nitroxoline and its derivatives are potent inhibitors of metallo-beta-lactamases. Eur J Med Chem. 2022;228:113975. doi:10.1016/j.ejmech.2021.113975
   PubMed Web of Science ®Google Scholar
• Principe L, Vecchio G, Sheehan G, et al. Zinc chelators as carbapenem adjuvants for metallo-beta-lactamase-producing bacteria: in vitro and in vivo evaluation. Microb Drug Resist. 2020;26:1133–1143. doi:10.1089/mdr.2020.0037
   PubMed Web of Science ®Google Scholar
• CLSI. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Vol. Clinical Laboratory Standards Institute M07-A09 (2012).
   Google Scholar
• Shang D, Zhang Q, Dong W, et al. The effects of LPS on the activity of Trp-containing antimicrobial peptides against Gram-negative bacteria and endotoxin neutralization. Acta Biomater. 2016;33:153–165. doi:10.1016/j.actbio.2016.01.019
   PubMed Web of Science ®Google Scholar
• Abraham MJ, Murtola T, Schulz R, et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX. 2015;1-2:19–25. doi:10.1016/j.softx.2015.06.001
   Google Scholar
• MacNair CR, Stokes JM, Carfrae LA, et al. Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics. Nat Commun. 2018;9:458. doi:10.1038/s41467-018-02875-z
   PubMed Web of Science ®Google Scholar
• Clifton LA, Skoda MWA, Le Brun AP, et al. Effect of divalent cation removal on the structure of gram-negative bacterial outer membrane models. Langmuir. 2015;31:404–412. doi:10.1021/la504407v
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother. 2009;53:5046–5054. doi:10.1128/AAC.00774-09
   PubMed Web of Science ®Google Scholar
• King AM, Reid-Yu SA, Wang W, et al. Aspergillomarasmine A overcomes metallo-beta-lactamase antibiotic resistance. Nature. 2014;510:503–506. doi:10.1038/nature13445
   PubMed Web of Science ®Google Scholar
• Guo Y, Wang J, Niu G, et al. A structural view of the antibiotic degradation enzyme NDM-1 from a superbug. Protein Cell. 2011;2:384–394. doi:10.1007/s13238-011-1055-9
   PubMed Web of Science ®Google Scholar
• Darby EM, Trampari E, Siasat P, et al. Molecular mechanisms of antibiotic resistance revisited. Nat Rev Microbiol. 2023;21:280–295. doi:10.1038/s41579-022-00820-y
   PubMed Web of Science ®Google Scholar
• Jernigan JA, Hatfield KM, Wolford H, et al. Multidrug-resistant bacterial infections in U.S. hospitalized patients, 2012-2017. N ENGL J MED. 2020;382:1309–1319. doi:10.1056/NEJMoa1914433
   PubMed Web of Science ®Google Scholar
• Tarin-Pello A, Suay-Garcia B, Perez-Gracia MT. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Expert Rev Anti Infect Ther. 2022;20:1095–1108. doi:10.1080/14787210.2022.2078308
   PubMed Web of Science ®Google Scholar
• Walsh C. Where will new antibiotics come from? Nat Rev Microbiol. 2003;1:65–70. doi:10.1038/nrmicro727
   PubMed Web of Science ®Google Scholar
• Liu Y, Tong Z, Shi J, et al. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria. Theranostics. 2021;11:4910–4928. doi:10.7150/thno.56205
   PubMed Web of Science ®Google Scholar
• Boyd NK, Teng C, Frei CR. Brief overview of approaches and challenges in new antibiotic development: a focus on drug repurposing. Front Cell Infect Microbiol. 2021;11:684515. doi:10.3389/fcimb.2021.684515
   PubMed Web of Science ®Google Scholar
• Kresken M, Korber-Irrgang B. In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany. Antimicrob Agents Chemother. 2014;58:7019–7020. doi:10.1128/AAC.03946-14
   PubMed Web of Science ®Google Scholar
• Naber KG, Niggemann H, Stein G, et al. Review of the literature and individual patients’ data meta-analysis on efficacy and tolerance of nitroxoline in the treatment of uncomplicated urinary tract infections. BMC Infect Dis. 2014;14:628. doi:10.1186/s12879-014-0628-7
   PubMed Web of Science ®Google Scholar
• Begic G, Petkovic Didovic M, Lucic Blagojevic S, et al. Adhesion of oral bacteria to commercial d-PTFE membranes: polymer microstructure makes a difference. Int J Mol Sci. 2022;23.
   Web of Science ®Google Scholar
• Sobke A, Klinger M, Hermann B, et al. The urinary antibiotic 5-nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of Pseudomonas aeruginosa biofilms by chelation of iron and zinc. Antimicrob Agents Chemother. 2012;56:6021–6025. doi:10.1128/AAC.01484-12
   PubMed Web of Science ®Google Scholar
• Fraser RS, Creanor J. The mechanism of inhibition of ribonucleic acid synthesis by 8-hydroxyquinoline and the antibiotic lomofungin. Biochem J. 1975;147:401–410. doi:10.1042/bj1470401
   PubMed Web of Science ®Google Scholar
• Vidaillac C, Benichou L, Duval RE. In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrob Agents Chemother. 2012;56:4856–4861. doi:10.1128/AAC.05996-11
   PubMed Web of Science ®Google Scholar
• Petrosillo N, Ioannidou E, Falagas ME. Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies. Clin Microbiol Infect. 2008;14:816–827. doi:10.1111/j.1469-0691.2008.02061.x
   PubMed Web of Science ®Google Scholar
• Deris ZZ, Yu HH, Davis K, et al. The combination of colistin and doripenem is synergistic against Klebsiella pneumoniae at multiple inocula and suppresses colistin resistance in an in vitro pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother. 2012;56:5103–5112. doi:10.1128/AAC.01064-12
   PubMed Web of Science ®Google Scholar
• Ling Z, Yin W, Shen Z, et al. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9. J Antimicrob Chemother. 2020;75:3087–3095. doi:10.1093/jac/dkaa205
   PubMed Web of Science ®Google Scholar
• Gonzalez LJ, Bahr G, Nakashige TG, et al. Membrane anchoring stabilizes and favors secretion of New Delhi metallo-beta-lactamase. Nat Chem Biol. 2016;12:516–522. doi:10.1038/nchembio.2083
   PubMed Web of Science ®Google Scholar
• Martinez MMB, Bonomo RA, Vila AJ, et al. On the offensive: the role of outer membrane vesicles in the successful dissemination of New Delhi Metallo-Beta-Lactamase (NDM-1). mBio. 2021;12:e0183621.
   PubMed Web of Science ®Google Scholar
• Yoshizumi A, Ishii Y, Kimura S, et al. Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 beta-lactamase. J Infect Chemother. 2013;19:992–995. doi:10.1007/s10156-012-0528-y
   PubMed Web of Science ®Google Scholar
• Wang R, Lai T-P, Gao P, et al. Bismuth antimicrobial drugs serve as broad-spectrum metallo-beta-lactamase inhibitors. Nat Commun. 2018;9:439. doi:10.1038/s41467-018-02828-6
   PubMed Web of Science ®Google Scholar
• Cheng Z, Thomas PW, Ju L, et al. Evolution of New Delhi metallo-beta-lactamase (NDM) in the clinic: effects of NDM mutations on stability, zinc affinity, and mono-zinc activity. J Biol Chem. 2018;293:12606–12618. doi:10.1074/jbc.RA118.003835
   PubMed Web of Science ®Google Scholar
• Bahr G, Vitor-Horen L, Bethel CR, et al. Clinical evolution of New Delhi metallo-beta-lactamase (NDM) optimizes resistance under Zn(II) deprivation. Antimicrob Agents Chemother. 2018; 62.
   PubMed Web of Science ®Google Scholar